Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

By adding soifenacin, the company says it can increase the tolerable dose of donepezil by 400%, which could translate into significantly improved cognition and function in Alzheimer's disease ...

CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a ...

Walter Moraes, MD, PhD; Dalva Poyares, MD, PhD; Lucia Sukys-Claudino, MD; Christian Guilleminault, MD, PhD; Sergio Tufik, MD, PhD In summary our results support the ...

Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine). There have been no ...

That drug was Cognex. Cognex is no longer prescribed due to difficult side effects and the development of better tolerated medications. The FDA has since approved three drugs for the treatment of mild ...

Our NICE Advice service will guide you there. Get reliable scientific advice and NHS insights, direct from NICE. We support companies seeking nationwide adoption of the best treatments and care. Our ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

Consisting of five separate booklets, the World Drug Report 2021 provides an in-depth analysis of the global drug markets and paints a comprehensive picture of the measurable effects and potential ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...